Literature DB >> 29315387

A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome.

Yoshiki Narimatsu1,2, Hiren J Joshi1, Zhang Yang1,2, Catarina Gomes1,3, Yen-Hsi Chen1, Flaminia C Lorenzetti1, Sanae Furukawa1, Katrine T Schjoldager1, Lars Hansen1, Henrik Clausen1, Eric P Bennett1, Hans H Wandall1.   

Abstract

Over 200 glycosyltransferases are involved in the orchestration of the biosynthesis of the human glycome, which is comprised of all glycan structures found on different glycoconjugates in cells. The glycome is vast, and despite advancements in analytic strategies it continues to be difficult to decipher biological roles of glycans with respect to specific glycan structures, type of glycoconjugate, particular glycoproteins, and distinct glycosites on proteins. In contrast to this, the number of glycosyltransferase genes involved in the biosynthesis of the human glycome is manageable, and the biosynthetic roles of most of these enzymes are defined or can be predicted with reasonable confidence. Thus, with the availability of the facile CRISPR/Cas9 gene editing tool it now seems easier to approach investigation of the functions of the glycome through genetic dissection of biosynthetic pathways, rather than by direct glycan analysis. However, obstacles still remain with design and validation of efficient gene targeting constructs, as well as with the interpretation of results from gene targeting and the translation of gene function to glycan structures. This is especially true for glycosylation steps covered by isoenzyme gene families. Here, we present a library of validated high-efficiency gRNA designs suitable for individual and combinatorial targeting of the human glycosyltransferase genome together with a global view of the predicted functions of human glycosyltransferases to facilitate and guide gene targeting strategies in studies of the human glycome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29315387     DOI: 10.1093/glycob/cwx101

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  36 in total

1.  An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells.

Authors:  Yoshiki Narimatsu; Hiren J Joshi; Rebecca Nason; Julie Van Coillie; Richard Karlsson; Lingbo Sun; Zilu Ye; Yen-Hsi Chen; Katrine T Schjoldager; Catharina Steentoft; Sanae Furukawa; Barbara A Bensing; Paul M Sullam; Andrew J Thompson; James C Paulson; Christian Büll; Gosse J Adema; Ulla Mandel; Lars Hansen; Eric Paul Bennett; Ajit Varki; Sergey Y Vakhrushev; Zhang Yang; Henrik Clausen
Journal:  Mol Cell       Date:  2019-06-18       Impact factor: 17.970

2.  A validated collection of mouse monoclonal antibodies to human glycosyltransferases functioning in mucin-type O-glycosylation.

Authors:  Catharina Steentoft; Zhang Yang; Shengjun Wang; Tongzhong Ju; Malene B Vester-Christensen; María F Festari; Sarah L King; Kelley Moremen; Ida S B Larsen; Christoffer K Goth; Katrine T Schjoldager; Lars Hansen; Eric P Bennett; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

Review 3.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

4.  Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases.

Authors:  Hiren J Joshi; Lars Hansen; Yoshiki Narimatsu; Hudson H Freeze; Bernard Henrissat; Eric Bennett; Hans H Wandall; Henrik Clausen; Katrine T Schjoldager
Journal:  Glycobiology       Date:  2018-05-01       Impact factor: 4.313

5.  A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.

Authors:  Catharina Steentoft; Max Fuhrmann; Federico Battisti; Julie Van Coillie; Thomas D Madsen; Diana Campos; Adnan Halim; Sergey Y Vakhrushev; Hiren J Joshi; Hans Schreiber; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-04-01       Impact factor: 4.313

6.  Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.

Authors:  Sarah Balderston; Gabrielle Clouse; Juan-José Ripoll; Grace K Pratt; Giedrius Gasiunas; Jens-Ole Bock; Eric Paul Bennett; Kiana Aran
Journal:  CRISPR J       Date:  2021-06

7.  Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.

Authors:  Joana Gomes; Celso A Reis; Joana G Rodrigues; Henrique O Duarte; Catarina Gomes; Meritxell Balmaña; Álvaro M Martins; Paul J Hensbergen; Arnoud H de Ru; Jorge Lima; André Albergaria; Peter A van Veelen; Manfred Wuhrer
Journal:  Cell Oncol (Dordr)       Date:  2021-04-13       Impact factor: 6.730

8.  ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab.

Authors:  Henrique O Duarte; Joana G Rodrigues; Catarina Gomes; Paul J Hensbergen; Agnes L Hipgrave Ederveen; Arnoud H de Ru; Stefan Mereiter; António Polónia; Elisabete Fernandes; José A Ferreira; Peter A van Veelen; Lúcio L Santos; Manfred Wuhrer; Joana Gomes; Celso A Reis
Journal:  Oncogene       Date:  2021-05-04       Impact factor: 9.867

Review 9.  Glycoengineering Chinese hamster ovary cells: a short history.

Authors:  Roberto Donini; Stuart M Haslam; Cleo Kontoravdi
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

10.  A GlycoGene CRISPR-Cas9 lentiviral library to study lectin binding and human glycan biosynthesis pathways.

Authors:  Yuqi Zhu; Theodore Groth; Anju Kelkar; Yusen Zhou; Sriram Neelamegham
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.